187 related articles for article (PubMed ID: 32354887)
41. Experimental generation of carcinoma-associated fibroblasts (CAFs) from human mammary fibroblasts.
Polanska UM; Acar A; Orimo A
J Vis Exp; 2011 Oct; (56):e3201. PubMed ID: 22064505
[TBL] [Abstract][Full Text] [Related]
42. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
[TBL] [Abstract][Full Text] [Related]
43. Hic-5 remodeling of the stromal matrix promotes breast tumor progression.
Goreczny GJ; Ouderkirk-Pecone JL; Olson EC; Krendel M; Turner CE
Oncogene; 2017 May; 36(19):2693-2703. PubMed ID: 27893716
[TBL] [Abstract][Full Text] [Related]
44. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
Nguyen F; Peña L; Ibisch C; Loussouarn D; Gama A; Rieder N; Belousov A; Campone M; Abadie J
Breast Cancer Res Treat; 2018 Feb; 167(3):635-648. PubMed ID: 29086231
[TBL] [Abstract][Full Text] [Related]
45. DDR2 Expression in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Tumor Invasion and Metastasis through Periostin-ITGB1.
Akinjiyan FA; Dave RM; Alpert E; Longmore GD; Fuh KC
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884543
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-8 expression associated with canine mammary tumors.
Zuccari DA; Castro R; Gelaleti GB; Mancini UM
Genet Mol Res; 2011; 10(3):1522-32. PubMed ID: 21863548
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
[TBL] [Abstract][Full Text] [Related]
48. [Effects of periostin on hepatocellular carcinoma cells invasion, metastasis and prognosis].
Wen Q; Shang J; Mise SRL; Bai L
Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):766-771. PubMed ID: 31734990
[No Abstract] [Full Text] [Related]
49. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development.
Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G
Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131
[TBL] [Abstract][Full Text] [Related]
50. The role of CD44 adhesion factor in canine mammary carcinomas.
Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
[TBL] [Abstract][Full Text] [Related]
51. Heat shock protein expression in canine malignant mammary tumours.
Romanucci M; Marinelli A; Sarli G; Della Salda L
BMC Cancer; 2006 Jun; 6():171. PubMed ID: 16803633
[TBL] [Abstract][Full Text] [Related]
52. CD26 expression is attenuated by TGF-β and SDF-1 autocrine signaling on stromal myofibroblasts in human breast cancers.
Mezawa Y; Daigo Y; Takano A; Miyagi Y; Yokose T; Yamashita T; Morimoto C; Hino O; Orimo A
Cancer Med; 2019 Jul; 8(8):3936-3948. PubMed ID: 31140748
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.
Bulkowska M; Rybicka A; Senses KM; Ulewicz K; Witt K; Szymanska J; Taciak B; Klopfleisch R; Hellmén E; Dolka I; Gure AO; Mucha J; Mikow M; Gizinski S; Krol M
BMC Cancer; 2017 Nov; 17(1):728. PubMed ID: 29115935
[TBL] [Abstract][Full Text] [Related]
54. Periostin Short Fragment with Exon 17 via Aberrant Alternative Splicing Is Required for Breast Cancer Growth and Metastasis.
Ikeda-Iwabu Y; Taniyama Y; Katsuragi N; Sanada F; Koibuchi N; Shibata K; Shimazu K; Rakugi H; Morishita R
Cells; 2021 Apr; 10(4):. PubMed ID: 33919736
[TBL] [Abstract][Full Text] [Related]
55. Periostin expression and its prognostic value for colorectal cancer.
Li Z; Zhang X; Yang Y; Yang S; Dong Z; Du L; Wang L; Wang C
Int J Mol Sci; 2015 May; 16(6):12108-18. PubMed ID: 26023718
[TBL] [Abstract][Full Text] [Related]
56. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
57. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
58. EGFR and microvessel density in canine malignant mammary tumours.
Carvalho MI; Guimarães MJ; Pires I; Prada J; Silva-Carvalho R; Lopes C; Queiroga FL
Res Vet Sci; 2013 Dec; 95(3):1094-9. PubMed ID: 24091029
[TBL] [Abstract][Full Text] [Related]
59. Expression of endothelin-1 and endothelin-1 receptor A in canine mammary tumours.
Restucci B; Martano M; Maiolino P
Res Vet Sci; 2015 Jun; 100():182-8. PubMed ID: 25816929
[TBL] [Abstract][Full Text] [Related]
60. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]